Breaking News

Syngene Launches Platform for Enhanced Protein Production

New platform is designed to streamline clone selection and enhance operational productivity.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Syngene International Ltd., a global contract research, development and manufacturing organization (CRDMO), launched its new protein production platform. The platform, using a cell line and transposon-based technology in-licensed from Swiss biotech services company, ExcellGene, coupled with Syngene’s clone selection and development processes, aims to provide significant improvement in efficiency and precision. The new platform offers enhanced protein production, enabling quicker preclinical and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters